Citations (115)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Adriana Pané, Sabina Ruiz, Aida Orois, Daniel Martínez, Mattia Squarcia, Lydia Sastre, Pablo Ruiz, Joan Caballería, Mireia Mora, Felicia A. Hanzu & Irene Halperin. (2018) Primary adrenal insufficiency due to hereditary apolipoprotein AI amyloidosis: endocrine involvement beyond hypogonadism. Amyloid 25:2, pages 75-78.
Read now
Read now
Hiroyuki Nakajima, Kazuchika Nishitsuji, Hiroyuki Kawashima, Kaori Kuwabara, Shiho Mikawa, Kenji Uchimura, Kenichi Akaji, Yoshiki Kashiwada, Norihiro Kobayashi, Hiroyuki Saito & Naomi Sakashita. (2016) The polyphenol (−)-epigallocatechin-3-gallate prevents apoA-IIowa amyloidosis in vitro and protects human embryonic kidney 293 cells against amyloid cytotoxicity. Amyloid 23:1, pages 17-25.
Read now
Read now
Maria Lorenza Muiesan, Massimo Salvetti, Anna Paini, Claudia Agabiti Rosei, Giulia Rubagotti, Alessandro Negrinelli, Gina Gregorini, Giovanni Cancarini, Laura Calabresi, Guido Franceschini, Laura Obici, Stefano Perlini, Giampaolo Merlini & Enrico Agabiti Rosei. (2015) Vascular alterations in apolipoprotein A-I amyloidosis (Leu75Pro). A case–control study. Amyloid 22:3, pages 187-193.
Read now
Read now
Daniela Braconi, Lia Millucci, Lorenzo Ghezzi & Annalisa Santucci. (2013) Redox proteomics gives insights into the role of oxidative stress in alkaptonuria. Expert Review of Proteomics 10:6, pages 521-535.
Read now
Read now
Monica Gomaraschi, Alice Ossoli, Cecilia Vitali & Laura Calabresi. (2013) HDL and endothelial protection: examining evidence from HDL inherited disorders. Clinical Lipidology 8:3, pages 361-370.
Read now
Read now
Candida Cristina Quarta, Laura Obici, Pier Luigi Guidalotti, Maurizio Pieroni, Simone Longhi, Stefano Perlini, Laura Verga, Giampaolo Merlini & Claudio Rapezzi. (2013) High 99mTc-DPD myocardial uptake in a patient with apolipoprotein AI-related amyloidotic cardiomyopathy. Amyloid 20:1, pages 48-51.
Read now
Read now
Daria Maria Monti, Sonia Di Gaetano, Rita Del Giudice, Chiara Giangrande, Angela Amoresano, Maria Monti, Angela Arciello & Renata Piccoli. (2012) Apolipoprotein A-I amyloidogenic variant L174S, expressed and isolated from stably transfected mammalian cells, is associated with fatty acids. Amyloid 19:1, pages 21-27.
Read now
Read now
Articles from other publishers (108)
Norihiro Namba, Takashi Ohgita, Hiroko Tamagaki-Asahina, Kazuchika Nishitsuji, Toshinori Shimanouchi, Takeshi Sato & Hiroyuki Saito. (2023) Amyloidogenic 60–71 deletion/ValThr insertion mutation of apolipoprotein A-I generates a new aggregation-prone segment that promotes nucleation through entropic effects. Scientific Reports 13:1.
Crossref
Crossref
Paolo Facondo, Andrea Delbarba, Letizia Chiara Pezzaioli, Alberto Ferlin & Carlo Cappelli. (2023) Osteoporosis in men with hypogonadism because of ApoA‐I Leu75Pro amyloidosis under long‐term testosterone therapy. Andrology 11:6, pages 1077-1085.
Crossref
Crossref
Adam Ioannou, Aldostefano Porcari, Rishi K. Patel, Yousuf Razvi, Giulio SinigianiAna Martinez-NaharroLucia VenneriJames Moon, Muhammad U. Rauf, Helen LachmannAshutosh WechelakarPhilip N. Hawkins, Julian D. Gillmore & Marianna Fontana. (2023) Rare Forms of Cardiac Amyloidosis: Diagnostic Clues and Phenotype in Apo AI and AIV Amyloidosis. Circulation: Cardiovascular Imaging 16:7, pages 523-535.
Crossref
Crossref
Karan Sud, Navneet Narula, Elena Aikawa, Eloisa Arbustini, Philippe Pibarot, Giampaolo Merlini, Robert S. Rosenson, Surya V. Seshan, Edgar Argulian, Amir Ahmadi, Fang Zhou, Andre L. Moreira, Nancy Côté, Sotirios Tsimikas, Valentin Fuster, Sam Gandy, Robert O. Bonow, Olga Gursky & Jagat Narula. (2023) The contribution of amyloid deposition in the aortic valve to calcification and aortic stenosis. Nature Reviews Cardiology 20:6, pages 418-428.
Crossref
Crossref
Chiara Pavanello & Alice Ossoli. (2023) HDL and chronic kidney disease. Atherosclerosis Plus 52, pages 9-17.
Crossref
Crossref
Rita Del Giudice, Mikaela Lindvall, Oktawia Nilsson, Daria Maria Monti & Jens O. Lagerstedt. (2022) The Apparent Organ-Specificity of Amyloidogenic ApoA-I Variants Is Linked to Tissue-Specific Extracellular Matrix Components. International Journal of Molecular Sciences 24:1, pages 318.
Crossref
Crossref
Rebecca Frankel, Emma Sparr & Sara Linse. (2022) On the Aggregation of Apolipoprotein A-I. International Journal of Molecular Sciences 23:15, pages 8780.
Crossref
Crossref
Rita Del Del Giudice, Paola Imbimbo, Federico Pietrocola, Isabelle Martins, Fatima Domenica Elisa De Palma, José Manuel Bravo-San Pedro, Guido Kroemer, Maria Chiara Maiuri & Daria Maria Monti. (2022) Autophagy Alteration in ApoA-I Related Systemic Amyloidosis. International Journal of Molecular Sciences 23:7, pages 3498.
Crossref
Crossref
Emily Lewkowicz & Olga Gursky. (2022) Dynamic protein structures in normal function and pathologic misfolding in systemic amyloidosis. Biophysical Chemistry 280, pages 106699.
Crossref
Crossref
Romina A. Gisonno, Tomas Masson, Nahuel A. Ramella, Exequiel E. Barrera, Víctor Romanowski & M. Alejandra Tricerri. (2021) Evolutionary and structural constraints influencing apolipoprotein A‐I amyloid behavior. Proteins: Structure, Function, and Bioinformatics 90:1, pages 258-269.
Crossref
Crossref
Rebecca Frankel, Katja Bernfur, Emma Sparr & Sara Linse. (2021) Purification and HDL-like particle formation of apolipoprotein A-I after co-expression with the EDDIE mutant of Npro autoprotease. Protein Expression and Purification 187, pages 105946.
Crossref
Crossref
Minxuan Yang, Zhijie Lu, Fenglin Li, Fei Shi, Fanbin Zhan, Yulei Zhang, Lijuan Zhao, Yanan Li, Jun Li, Li Lin & Zhendong Qin. (2021) Alginate oligosaccharide improves fat metabolism and antioxidant capacity in the liver of grass carp (Ctenopharyngodon idellus). Aquaculture 540, pages 736664.
Crossref
Crossref
Takaomi Sagawa, Tomomi Kogiso, Taito Ito, Hideo Yasuda, Nagaaki Katoh, Tsuneaki Yoshinaga, Masahide Yazaki, Takaaki Kato, Akiko Omori, Yoshihito Kotera, Hiroto Egawa, Masakazu Yamamoto & Katsutoshi Tokushige. (2021) Hereditary Apolipoprotein A-1 Amyloidosis With Glu34Lys Mutation Treated by Liver Transplantation: A Case Report. Transplantation Proceedings 53:4, pages 1327-1332.
Crossref
Crossref
Arianna Strazzella, Alice Ossoli & Laura Calabresi. (2021) High-Density Lipoproteins and the Kidney. Cells 10:4, pages 764.
Crossref
Crossref
Takashi Ohgita, Yuki Furutani, Miyu Nakano, Megumi Hattori, Ayane Suzuki, Miho Nakagawa, Sera Naniwa, Izumi Morita, Hiroyuki Oyama, Kazuchika Nishitsuji, Norihiro Kobayashi & Hiroyuki Saito. (2020) Novel conformation‐selective monoclonal antibodies against apoA‐I amyloid fibrils. The FEBS Journal 288:5, pages 1496-1513.
Crossref
Crossref
Tsuneaki Yoshinaga, Nagaaki Katoh, Masahide Yazaki, Mitsuto Sato, Fuyuki Kametani, Hideo Yasuda, Kyohei Watanabe, Kazuhito Kawata, Mayuko Nakagawa & Yoshiki Sekijima. (2021) Giant Hepatomegaly with Spleno-testicular Enlargement in a Patient with Apolipoprotein A-I Amyloidosis: An Uncommon Type of Amyloidosis in Japan. Internal Medicine 60:4, pages 575-581.
Crossref
Crossref
Oktawia Nilsson, Mikaela Lindvall, Laura Obici, Simon Ekström, Jens O. Lagerstedt & Rita Del Giudice. (2021) Structure dynamics of ApoA-I amyloidogenic variants in small HDL increase their ability to mediate cholesterol efflux. Journal of Lipid Research 62, pages 100004.
Crossref
Crossref
Xiaoxiao Zhang, Xiaoqian Ma, Tao Gan, Yunfan Shi, Yuan Wang & Qiuyun Liu. (2020) Secondary Chemical Bonding between Insoluble Calcium Oxalate and Carbonyl Oxygen Atoms of GLY and VAL Residues Triggers the Formation of Aβ Aggregates and Their Deposition in the Brain. ACS Chemical Neuroscience 11:24, pages 4007-4011.
Crossref
Crossref
Andrea Delbarba, Paolo Facondo, Simona Fisogni, Claudia Izzi, Filippo Maffezzoni, Letizia Chiara Pezzaioli, Elena Di Lodovico, Fabio Facchetti, Carlo Cappelli, Francesco Scolari & Alberto Ferlin. (2020) Testicular Involvement is a Hallmark of Apo A-I Leu75Pro Mutation Amyloidosis. The Journal of Clinical Endocrinology & Metabolism 105:12, pages e4758-e4766.
Crossref
Crossref
Farah Ma'arfi, Subhash Chandra Prasad, Jamal e Fatima, Mohd Yasir Khan, Snober S. Mir & Mohd Aslam Yusuf. (2020) Probing the Structure–Function relationship and amyloidogenic propensities in natural variants of apolipoprotein A-I. Biochemistry and Biophysics Reports 24, pages 100815.
Crossref
Crossref
Fei Shi, Yingjuan Zi, Zhijie Lu, Fenglin Li, Minxuan Yang, Fanbin Zhan, Yanan Li, Jun Li, Lijuan Zhao, Li Lin & Zhendong Qin. (2020) Bacillus subtilis H2 modulates immune response, fat metabolism and bacterial flora in the gut of grass carp (Ctenopharyngodon idellus). Fish & Shellfish Immunology 106, pages 8-20.
Crossref
Crossref
Lidia Ciccone, Chenghui Shi, Davide di Lorenzo, Anne-Cécile Van Baelen & Nicolo Tonali. (2020) The Positive Side of the Alzheimer’s Disease Amyloid Cross-Interactions: The Case of the Aβ 1-42 Peptide with Tau, TTR, CysC, and ApoA1. Molecules 25:10, pages 2439.
Crossref
Crossref
Naoko Kurimitsu, Chiharu Mizuguchi, Kaho Fujita, Suzuno Taguchi, Takashi Ohgita, Kazuchika Nishitsuji, Toshinori Shimanouchi & Hiroyuki Saito. (2020) Phosphatidylethanolamine accelerates aggregation of the amyloidogenic N‐terminal fragment of apoA‐I. FEBS Letters 594:9, pages 1443-1452.
Crossref
Crossref
Danyang Li, Dan Liu, Hui Xu, Xiao-juan Yu, Fu-de Zhou, Ming-hui Zhao & Su-xia Wang. (2019) Typing of hereditary renal amyloidosis presenting with isolated glomerular amyloid deposition. BMC Nephrology 20:1.
Crossref
Crossref
Myrto Moutafi, Dimitrios C. Ziogas, Spyros Michopoulos, Tina Bagratuni, Vassiliki Vasileiou, Laura Verga, Giampaolo Merlini, Giovanni Palladini, Charis Matsouka, Meletios A. Dimopoulos & Efstathios Kastritis. (2019) A new genetic variant of hereditary apolipoprotein A-I amyloidosis: a case-report followed by discussion of diagnostic challenges and therapeutic options. BMC Medical Genetics 20:1.
Crossref
Crossref
Chiharu Mizuguchi, Miho Nakagawa, Norihiro Namba, Misae Sakai, Naoko Kurimitsu, Ayane Suzuki, Kaho Fujita, Sayaka Horiuchi, Teruhiko Baba, Takashi Ohgita, Kazuchika Nishitsuji & Hiroyuki Saito. (2019) Mechanisms of aggregation and fibril formation of the amyloidogenic N-terminal fragment of apolipoprotein A-I. Journal of Biological Chemistry 294:36, pages 13515-13524.
Crossref
Crossref
Geoffrey J. Howlett, Timothy M. Ryan & Michael D.W. Griffin. (2019) Lipid-apolipoprotein interactions in amyloid fibril formation and relevance to atherosclerosis. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1867:5, pages 502-507.
Crossref
Crossref
Dennis Wilkens Juhl, Michael Wulff Risør, Carsten Scavenius, Casper Bøjer Rasmussen, Daniel Otzen, Niels Chr. Nielsen & Jan J. Enghild. (2019) Conservation of the Amyloid Interactome Across Diverse Fibrillar Structures. Scientific Reports 9:1.
Crossref
Crossref
Rita Del Giudice & Jens O. Lagerstedt. (2018) High-efficient bacterial production of human ApoA-I amyloidogenic variants. Protein Science 27:12, pages 2101-2109.
Crossref
Crossref
Isabel Morgado, Afra Panahi, Andrew G. Burwash, Madhurima Das, John E. Straub & Olga Gursky. (2018) Molecular Insights into Human Hereditary Apolipoprotein A-I Amyloidosis Caused by the Glu34Lys Mutation. Biochemistry 57:39, pages 5738-5747.
Crossref
Crossref
Galyna P. Gorbenko, Valeriya Trusova, Chiharu Mizuguchi & Hiroyuki Saito. (2018) Lipid Bilayer Interactions of Amyloidogenic N-Terminal Fragment of Apolipoprotein A-I Probed by Förster Resonance Energy Transfer and Molecular Dynamics Simulations. Journal of Fluorescence 28:5, pages 1037-1047.
Crossref
Crossref
David Townsend, Eleri Hughes, Geoffrey Akien, Katie L. Stewart, Sheena E. Radford, David Rochester & David A. Middleton. (2018) Epigallocatechin-3-gallate remodels apolipoprotein A-I amyloid fibrils into soluble oligomers in the presence of heparin. Journal of Biological Chemistry 293:33, pages 12877-12893.
Crossref
Crossref
Rita Del Giudice, Alessandra Pesce, Flora Cozzolino, Maria Monti, Annalisa Relini, Renata Piccoli, Angela Arciello & Daria Maria Monti. (2018) Effects of iron on the aggregation propensity of the N-terminal fibrillogenic polypeptide of human apolipoprotein A-I. BioMetals 31:4, pages 551-559.
Crossref
Crossref
Christopher J. Wilson, Madhurima Das, Shobini Jayaraman, Olga Gursky & John R. Engen. (2018) Effects of Disease-Causing Mutations on the Conformation of Human Apolipoprotein A-I in Model Lipoproteins. Biochemistry 57:30, pages 4583-4596.
Crossref
Crossref
Susanne Dogan, Michael Paulus, Yury Forov, Christopher Weis, Matthias Kampmann, Christopher Cewe, Irena Kiesel, Patrick Degen, Paul Salmen, Heinz Rehage & Metin Tolan. (2018) Human Apolipoprotein A1 at Solid/Liquid and Liquid/Gas Interfaces. The Journal of Physical Chemistry B 122:14, pages 3953-3960.
Crossref
Crossref
Chiharu Mizuguchi, Mitsuki Nakamura, Naoko Kurimitsu, Takashi Ohgita, Kazuchika Nishitsuji, Teruhiko Baba, Akira Shigenaga, Toshinori Shimanouchi, Keiichiro Okuhira, Akira Otaka & Hiroyuki Saito. (2018) Effect of Phosphatidylserine and Cholesterol on Membrane-mediated Fibril Formation by the N-terminal Amyloidogenic Fragment of Apolipoprotein A-I. Scientific Reports 8:1.
Crossref
Crossref
Rosa Gaglione, Giovanni Smaldone, Rocco Di Girolamo, Renata Piccoli, Emilia Pedone & Angela Arciello. (2018) Cell milieu significantly affects the fate of AApoAI amyloidogenic variants: predestination or serendipity?. Biochimica et Biophysica Acta (BBA) - General Subjects 1862:3, pages 377-384.
Crossref
Crossref
Shannon F. Rudy, Caroline C. Jeffery & Edward J. Damrose. (2018) Clinical characteristics of laryngeal versus nonlaryngeal amyloidosis. The Laryngoscope 128:3, pages 670-674.
Crossref
Crossref
Mihaly Varadi, Greet De Baets, Wim F Vranken, Peter Tompa & Rita Pancsa. (2018) AmyPro: a database of proteins with validated amyloidogenic regions. Nucleic Acids Research 46:D1, pages D387-D392.
Crossref
Crossref
Rita Del Giudice, Joan Domingo-Espín, Ilaria Iacobucci, Oktawia Nilsson, Maria Monti, Daria Maria Monti & Jens O. Lagerstedt. (2017) Structural determinants in ApoA-I amyloidogenic variants explain improved cholesterol metabolism despite low HDL levels. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1863:12, pages 3038-3048.
Crossref
Crossref
Silvana A. Rosú, Leandro Toledo, Bruno F. Urbano, Susana A. Sanchez, Graciela C. Calabrese & M. Alejandra Tricerri. (2017) Learning from Synthetic Models of Extracellular Matrix; Differential Binding of Wild Type and Amyloidogenic Human Apolipoprotein A-I to Hydrogels Formed from Molecules Having Charges Similar to Those Found in Natural GAGs. The Protein Journal 36:4, pages 374-383.
Crossref
Crossref
David Townsend, Eleri Hughes, Rohanah Hussain, Giuliano Siligardi, Sarah Baldock, Jillian Madine & David A. Middleton. (2017) Heparin and Methionine Oxidation Promote the Formation of Apolipoprotein A-I Amyloid Comprising α-Helical and β-Sheet Structures. Biochemistry 56:11, pages 1632-1644.
Crossref
Crossref
Michael N. Oda. (2017) Lipid-free apoA-I structure - Origins of model diversity. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1862:2, pages 221-233.
Crossref
Crossref
Shobini Jayaraman, Jose Luis Sánchez-Quesada & Olga Gursky. (2017) Triglyceride increase in the core of high-density lipoproteins augments apolipoprotein dissociation from the surface: Potential implications for treatment of apolipoprotein deposition diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1863:1, pages 200-210.
Crossref
Crossref
Angela Arciello, Renata Piccoli & Daria Maria Monti. (2016) Apolipoprotein A-I: the dual face of a protein. FEBS Letters 590:23, pages 4171-4179.
Crossref
Crossref
Shiho Mikawa, Chiharu Mizuguchi, Kazuchika Nishitsuji, Teruhiko Baba, Akira Shigenaga, Toshinori Shimanouchi, Naomi Sakashita, Akira Otaka, Kenichi Akaji & Hiroyuki Saito. (2016) Heparin promotes fibril formation by the N-terminal fragment of amyloidogenic apolipoprotein A-I. FEBS Letters 590:20, pages 3492-3500.
Crossref
Crossref
Birgitte G. Tougaard, Katja Venborg Pedersen, Søren Rasmus Krag, Janet A. Gilbertson, Dorota Rowczenio, Julian D. Gillmore & Henrik Birn. (2016) A case report of hereditary apolipoprotein A-I amyloidosis associated with a novel APOA1 mutation and variable phenotype. European Journal of Medical Genetics 59:9, pages 474-477.
Crossref
Crossref
Jinghui Luo, Sebastian K.T.S. Wärmländer, Astrid Gräslund & Jan Pieter Abrahams. (2016) Cross-interactions between the Alzheimer Disease Amyloid-β Peptide and Other Amyloid Proteins: A Further Aspect of the Amyloid Cascade Hypothesis. Journal of Biological Chemistry 291:32, pages 16485-16493.
Crossref
Crossref
Hirokazu Kameyama, Hiroyuki Nakajima, Kazuchika Nishitsuji, Shiho Mikawa, Kenji Uchimura, Norihiro Kobayashi, Keiichiro Okuhira, Hiroyuki Saito & Naomi Sakashita. (2016) Iowa Mutant Apolipoprotein A-I (ApoA-IIowa) Fibrils Target Lysosomes. Scientific Reports 6:1.
Crossref
Crossref
Giulia Rusciano, Giuseppe Pesce, Gianluigi Zito, Antonio Sasso, Rosa Gaglione, Rita Del Giudice, Renata Piccoli, Daria Maria Monti & Angela Arciello. (2016) Insights into the interaction of the N-terminal amyloidogenic polypeptide of ApoA-I with model cellular membranes. Biochimica et Biophysica Acta (BBA) - General Subjects 1860:4, pages 795-801.
Crossref
Crossref
Rita Del Giudice, Angela Arciello, Francesco Itri, Antonello Merlino, Maria Monti, Martina Buonanno, Amanda Penco, Diana Canetti, Ganna Petruk, Simona Maria Monti, Annalisa Relini, Piero Pucci, Renata Piccoli & Daria Maria Monti. (2016) Protein conformational perturbations in hereditary amyloidosis: Differential impact of single point mutations in ApoAI amyloidogenic variants. Biochimica et Biophysica Acta (BBA) - General Subjects 1860:2, pages 434-444.
Crossref
Crossref
Madhurima Das, Christopher J. Wilson, Xiaohu Mei, Thomas E. Wales, John R. Engen & Olga Gursky. (2016) Structural Stability and Local Dynamics in Disease-Causing Mutants of Human Apolipoprotein A-I: What Makes the Protein Amyloidogenic?. Journal of Molecular Biology 428:2, pages 449-462.
Crossref
Crossref
Jonathan Dalla-Riva, Jens O. Lagerstedt & Jitka Petrlova. (2015) Structural and Functional Analysis of the ApolipoproteinA-I A164S Variant. PLOS ONE 10:11, pages e0143915.
Crossref
Crossref
Kaori Kuwabara, Kazuchika Nishitsuji, Kenji Uchimura, Shang-Cheng Hung, Makoto Mizuguchi, Hiroyuki Nakajima, Shiho Mikawa, Norihiro Kobayashi, Hiroyuki Saito & Naomi Sakashita. (2015) Cellular Interaction and Cytotoxicity of the Iowa Mutation of Apolipoprotein A-I (ApoA-IIowa) Amyloid Mediated by Sulfate Moieties of Heparan Sulfate. Journal of Biological Chemistry 290:40, pages 24210-24221.
Crossref
Crossref
Chiharu Mizuguchi, Fuka Ogata, Shiho Mikawa, Kohei Tsuji, Teruhiko Baba, Akira Shigenaga, Toshinori Shimanouchi, Keiichiro Okuhira, Akira Otaka & Hiroyuki Saito. (2015) Amyloidogenic Mutation Promotes Fibril Formation of the N-terminal Apolipoprotein A-I on Lipid Membranes. Journal of Biological Chemistry 290:34, pages 20947-20959.
Crossref
Crossref
Nikolaos N. Louros, Paraskevi L. Tsiolaki, Michael D.W. Griffin, Geoffrey J. Howlett, Stavros J. Hamodrakas & Vassiliki A. Iconomidou. (2015) Chameleon ‘aggregation-prone’ segments of apoA-I: A model of amyloid fibrils formed in apoA-I amyloidosis. International Journal of Biological Macromolecules 79, pages 711-718.
Crossref
Crossref
Gina Gregorini, Claudia Izzi, Pietro Ravani, Laura Obici, Nadia Dallera, Andrea Del Barba, Alessandro Negrinelli, Regina Tardanico, Matilde Nardi, Luciano Biasi, Tiziano Scalvini, Giampaolo Merlini & Francesco Scolari. (2015) Tubulointerstitial nephritis is a dominant feature of hereditary apolipoprotein A-I amyloidosis. Kidney International 87:6, pages 1223-1229.
Crossref
Crossref
Silvana A. Rosú, Omar J. Rimoldi, Eduardo D. Prieto, Lucrecia M. Curto, José M. Delfino, Nahuel A. Ramella & M. Alejandra Tricerri. (2015) Amyloidogenic Propensity of a Natural Variant of Human Apolipoprotein A-I: Stability and Interaction with Ligands. PLOS ONE 10:5, pages e0124946.
Crossref
Crossref
Simone Longhi, Rachele Bonfiglioli, Laura Obici, Christian Gagliardi, Agnese Milandri, Massimiliano Lorenzini, Pier Luigi Guidalotti, Giampaolo Merlini & Claudio Rapezzi. (2015) Etiology of Amyloidosis Determines Myocardial 99mTc-DPD Uptake in Amyloidotic Cardiomyopathy. Clinical Nuclear Medicine 40:5, pages 446-447.
Crossref
Crossref
Gary K.L. Chan, Andrzej Witkowski, Donald L. Gantz, Tianqi O. Zhang, Martin T. Zanni, Shobini Jayaraman & Giorgio Cavigiolio. (2015) Myeloperoxidase-mediated Methionine Oxidation Promotes an Amyloidogenic Outcome for Apolipoprotein A-I. Journal of Biological Chemistry 290:17, pages 10958-10971.
Crossref
Crossref
Liam R. Brunham & Michael R. Hayden. (2015) Human genetics of HDL: Insight into particle metabolism and function. Progress in Lipid Research 58, pages 14-25.
Crossref
Crossref
Rabya H. Sayed, Philip N. Hawkins & Helen J. Lachmann. (2015) Emerging treatments for amyloidosis. Kidney International 87:3, pages 516-526.
Crossref
Crossref
Valeriya Trusova, Galyna Gorbenko, Mykhailo Girych, Emi Adachi, Chiharu Mizuguchi, Rohit Sood, Paavo Kinnunen & Hiroyuki Saito. (2015) Membrane Effects of N-Terminal Fragment of Apolipoprotein A-I: A Fluorescent Probe Study. Journal of Fluorescence 25:2, pages 253-261.
Crossref
Crossref
Lianqi Huang, Xinran Liu, Biao Cheng & Kun Huang. (2015) How our bodies fight amyloidosis: Effects of physiological factors on pathogenic aggregation of amyloidogenic proteins. Archives of Biochemistry and Biophysics 568, pages 46-55.
Crossref
Crossref
Mario Nuvolone, Giovanni Palladini & Giampaolo Merlini. 2015. Amyloid and Related Disorders. Amyloid and Related Disorders
9
29
.
Madhurima Das & Olga Gursky. 2015. Lipids in Protein Misfolding. Lipids in Protein Misfolding
175
211
.
Timothy M. Ryan, Yee-Foong Mok, Geoffrey J. Howlett & Michael D. W. Griffin. 2015. Lipids in Protein Misfolding. Lipids in Protein Misfolding
157
174
.
Galyna Gorbenko, Valeriya Trusova, Mykhailo Girych, Emi Adachi, Chiharu Mizuguchi & Hiroyuki Saito. 2015. Lipids in Protein Misfolding. Lipids in Protein Misfolding
135
155
.
Nicole K. Andeen, Daniel Y. Lam, Ian H. de Boer & Roberto F. Nicosia. (2014) Renal ApoA-1 Amyloidosis with Glu34Lys Mutation and Intra-amyloid Lipid Accumulation. Journal of the American Society of Nephrology 25:12, pages 2703-2705.
Crossref
Crossref
Massimiliano Godani, Roberta Baldi, Elisa Raggio, Elisabetta Traverso, Elisa Giorli & Massimo Del Sette. (2014) Low Apolipoprotein A-1 Plasma Level in Older Adults with Spontaneous Cerebral Lobar Hemorrhage: A Cross-Sectional Study. Journal of the American Geriatrics Society 62:12, pages 2437-2438.
Crossref
Crossref
Jitka Petrlova, Arnab Bhattacherjee, Wouter Boomsma, Stefan Wallin, Jens O. Lagerstedt & Anders Irbäck. (2014) Conformational and aggregation properties of the 1-93 fragment of apolipoprotein A-I. Protein Science 23:11, pages 1559-1571.
Crossref
Crossref
C. Vitali, C. L. Wellington & L. Calabresi. (2014) HDL and cholesterol handling in the brain. Cardiovascular Research 103:3, pages 405-413.
Crossref
Crossref
Madhurima Das, Xiaohu Mei, Shobini Jayaraman, David Atkinson & Olga Gursky. (2014) Amyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing - a common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosis. FEBS Journal 281:11, pages 2525-2542.
Crossref
Crossref
Michel de Messieres, Rick K. Huang, Yi He & Jennifer C. Lee. (2014) Amyloid Triangles, Squares, and Loops of Apolipoprotein C-III. Biochemistry 53:20, pages 3261-3263.
Crossref
Crossref
M. A. Khalighi, W. Dean Wallace & M. F. Palma-Diaz. (2014) Amyloid nephropathy. Clinical Kidney Journal 7:2, pages 97-106.
Crossref
Crossref
Olga Gursky. (2014) Hot spots in apolipoprotein A‐II misfolding and amyloidosis in mice and men. FEBS Letters 588:6, pages 845-850.
Crossref
Crossref
R Del Giudice, D M Monti, C Sarcinelli, A Arciello, R Piccoli & G-F Hu. (2014) Amyloidogenic variant of apolipoprotein A-I elicits cellular stress by attenuating the protective activity of angiogenin. Cell Death & Disease 5:3, pages e1097-e1097.
Crossref
Crossref
Emi Adachi, Asako Kosaka, Kohei Tsuji, Chiharu Mizuguchi, Hiroyuki Kawashima, Akira Shigenaga, Kohjiro Nagao, Kenichi Akaji, Akira Otaka & Hiroyuki Saito. (2014) The extreme N-terminal region of human apolipoprotein A-I has a strong propensity to form amyloid fibrils. FEBS Letters 588:3, pages 389-394.
Crossref
Crossref
Akira Matsunaga. 2014. The HDL Handbook. The HDL Handbook
9
35
.
Giovanni Palladini & Giampaolo Merlini. (2013) Systemic amyloidoses: What an internist should know. European Journal of Internal Medicine 24:8, pages 729-739.
Crossref
Crossref
Emi Adachi, Hiroyuki Nakajima, Chiharu Mizuguchi, Padmaja Dhanasekaran, Hiroyuki Kawashima, Kohjiro Nagao, Kenichi Akaji, Sissel Lund-Katz, Michael C. Phillips & Hiroyuki Saito. (2013) Dual Role of an N-terminal Amyloidogenic Mutation in Apolipoprotein A-I. Journal of Biological Chemistry 288:4, pages 2848-2856.
Crossref
Crossref
Adam J. Loavenbruck, Vinay Chaudhry, Steven R. Zeldenrust, Robert J. Spinner, Jason D. Theis & Christopher J. Klein. (2012) Mass spectrometry analysis reveals non-mutated apolipoprotein a1 lumbosacral radiculoplexus amyloidoma. Muscle & Nerve 46:5, pages 817-822.
Crossref
Crossref
Gaetano Invernizzi, Elena Papaleo, Raimon Sabate & Salvador Ventura. (2012) Protein aggregation: Mechanisms and functional consequences. The International Journal of Biochemistry & Cell Biology 44:9, pages 1541-1554.
Crossref
Crossref
Jitka Petrlova, Trang Duong, Megan C. Cochran, Annika Axelsson, Matthias Mörgelin, Linda M. Roberts & Jens O. Lagerstedt. (2012) The fibrillogenic L178H variant of apolipoprotein A-I forms helical fibrils. Journal of Lipid Research 53:3, pages 390-398.
Crossref
Crossref
Olga Gursky, Xiaohu Mei & David Atkinson. (2011) The Crystal Structure of the C-Terminal Truncated Apolipoprotein A-I Sheds New Light on Amyloid Formation by the N-Terminal Fragment. Biochemistry 51:1, pages 10-18.
Crossref
Crossref
Sanjeev Sethi, Jason D. Theis, Shirley M. Shiller, Cynthia C. Nast, David Harrison, Helmut G. Rennke, Julie A. Vrana & Ahmet Dogan. (2012) Medullary amyloidosis associated with apolipoprotein A-IV deposition. Kidney International 81:2, pages 201-206.
Crossref
Crossref
Mario Nuvolone, Giovanni Palladini & Giampaolo Merlini. 2012. Amyloid and Related Disorders. Amyloid and Related Disorders
9
29
.
Angela Arciello, Nadia De Marco, Rita Del Giudice, Fulvio Guglielmi, Piero Pucci, Annalisa Relini, Daria Maria Monti & Renata Piccoli. (2011) Insights into the fate of the N-terminal amyloidogenic polypeptide of ApoA-I in cultured target cells. Journal of Cellular and Molecular Medicine 15:12, pages 2652-2663.
Crossref
Crossref
Massimiliano Godani, Cesare Capellini & Massimo Del Sette. (2011) Apolipoprotein A‐1 Deficiency in Older Adults with Spontaneous Cerebral Lobar Hemorrhage. Journal of the American Geriatrics Society 59:12, pages 2372-2373.
Crossref
Crossref
Timothy M. Ryan, Michael D. W. Griffin, Michael F. Bailey, Peter Schuck & Geoffrey J. Howlett. (2011) NBD-Labeled Phospholipid Accelerates Apolipoprotein C-II Amyloid Fibril Formation but Is Not Incorporated into Mature Fibrils. Biochemistry 50:44, pages 9579-9586.
Crossref
Crossref
Nahuel A. Ramella, Omar J. Rimoldi, Eduardo D. Prieto, Guillermo R. Schinella, Susana A. Sanchez, María S. Jaureguiberry, María E. Vela, Sergio T. Ferreira & M. Alejandra Tricerri. (2011) Human Apolipoprotein A-I-Derived Amyloid: Its Association with Atherosclerosis. PLoS ONE 6:7, pages e22532.
Crossref
Crossref
Monica Gomaraschi, Laura Obici, Sara Simonelli, Gina Gregorini, Alessandro Negrinelli, Giampaolo Merlini, Guido Franceschini & Laura Calabresi. (2011) Effect of the amyloidogenic L75P apolipoprotein A-I variant on HDL subpopulations. Clinica Chimica Acta 412:13-14, pages 1262-1265.
Crossref
Crossref
Sara Raimondi, Fulvio Guglielmi, Sofia Giorgetti, Sonia Di Gaetano, Angela Arciello, Daria M. Monti, Annalisa Relini, Daniela Nichino, Silvia M. Doglia, Antonino Natalello, Piero Pucci, Palma Mangione, Laura Obici, Giampaolo Merlini, Monica Stoppini, Paul Robustelli, Gian Gaetano Tartaglia, Michele Vendruscolo, Christopher M. Dobson, Renata Piccoli & Vittorio Bellotti. (2011) Effects of the Known Pathogenic Mutations on the Aggregation Pathway of the Amyloidogenic Peptide of Apolipoprotein A-I. Journal of Molecular Biology 407:3, pages 465-476.
Crossref
Crossref
Chai Lean Teoh, Michael D. W. Griffin & Geoffrey J. Howlett. (2011) Apolipoproteins and amyloid fibril formation in atherosclerosis. Protein & Cell 2:2, pages 116-127.
Crossref
Crossref
Paul M.M. Weers, Arti B. Patel, Leon C-P. Wan, Emmanuel Guigard, Cyril M. Kay, Anouar Hafiane, Ruth McPherson, Yves L. Marcel & Robert S. Kiss. (2011) Novel N-terminal mutation of human apolipoprotein A-I reduces self-association and impairs LCAT activation. Journal of Lipid Research 52:1, pages 35-44.
Crossref
Crossref
Marta Marchesi, Cinzia Parolini, Caterina Valetti, Palma Mangione, Laura Obici, Sofia Giorgetti, Sara Raimondi, Simona Donadei, Gina Gregorini, Giampaolo Merlini, Monica Stoppini, Giulia Chiesa & Vittorio Bellotti. (2011) The intracellular quality control system down-regulates the secretion of amyloidogenic apolipoprotein A-I variants: A possible impact on the natural history of the disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1812:1, pages 87-93.
Crossref
Crossref
Daria Maria Monti, Fulvio Guglielmi, Maria Monti, Flora Cozzolino, Silvia Torrassa, Annalisa Relini, Piero Pucci, Angela Arciello & Renata Piccoli. (2010) Effects of a lipid environment on the fibrillogenic pathway of the N-terminal polypeptide of human apolipoprotein A-I, responsible for in vivo amyloid fibril formation. European Biophysics Journal 39:9, pages 1289-1299.
Crossref
Crossref
Yuan Qi Wong, Katrina J. Binger, Geoffrey J. Howlett & Michael D. W. Griffin. (2010) Methionine oxidation induces amyloid fibril formation by full-length apolipoprotein A-I. Proceedings of the National Academy of Sciences 107:5, pages 1977-1982.
Crossref
Crossref
Francesca Lavatelli, Giovanni Palladini & Giampaolo Merlini. 2010. Amyloidosis. Amyloidosis
49
64
.
Guido Francheschini. 2010. High Density Lipoproteins, Dyslipidemia, and Coronary Heart Disease. High Density Lipoproteins, Dyslipidemia, and Coronary Heart Disease
63
69
.
Natalie A. Ciaccio & Jennifer S. Laurence. (2009) Effects of Disulfide Bond Formation and Protein Helicity on the Aggregation of Activating Transcription Factor 5. Molecular Pharmaceutics 6:4, pages 1205-1215.
Crossref
Crossref
Andréa C. Paula-Lima, M. Alejandra Tricerri, Jordano Brito-Moreira, Theresa R. Bomfim, Fabio F. Oliveira, Margaret H. Magdesian, Lea T. Grinberg, Rogerio Panizzutti & Sérgio T. Ferreira. (2009) Human apolipoprotein A–I binds amyloid-β and prevents Aβ-induced neurotoxicity. The International Journal of Biochemistry & Cell Biology 41:6, pages 1361-1370.
Crossref
Crossref
J. Tan & J.L. Brash. (2008) Nonfouling biomaterials based on polyethylene oxide‐containing amphiphilic triblock copolymers as surface modifying additives: Adsorption of proteins from human plasma to copolymer/polyurethane blends. Journal of Biomedical Materials Research Part A 90A:1, pages 196-204.
Crossref
Crossref
Magdalena Eriksson, Stefan Schönland, Saniye Yumlu, Ute Hegenbart, Hanna von Hutten, Zarina Gioeva, Peter Lohse, Janine Büttner, Hartmut Schmidt & Christoph Röcken. (2009) Hereditary Apolipoprotein AI-Associated Amyloidosis in Surgical Pathology Specimens. The Journal of Molecular Diagnostics 11:3, pages 257-262.
Crossref
Crossref
Monica Stoppini, Laura Obici, Francesca Lavatelli, Sofia Giorgetti, Loredana Marchese, Remigio Moratti, Vittorio Bellotti & Giampaolo Merlini. (2009) Proteomics in protein misfolding diseases. Clinical Chemistry and Laboratory Medicine 47:6.
Crossref
Crossref
Vittorio Bellotti & Fabrizio Chiti. (2008) Amyloidogenesis in its biological environment: challenging a fundamental issue in protein misfolding diseases. Current Opinion in Structural Biology 18:6, pages 771-779.
Crossref
Crossref
Márcia Almeida Liz, Cláudio M. Gomes, Maria João Saraiva & Mónica Mendes Sousa. (2007) ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity. Journal of Lipid Research 48:11, pages 2385-2395.
Crossref
Crossref
Sonia Di Gaetano, Fulvio Guglielmi, Angela Arciello, Palma Mangione, Maria Monti, Daniela Pagnozzi, Sara Raimondi, Sofia Giorgetti, Stefania Orrù, Claudio Canale, Piero Pucci, Christopher M. Dobson, Vittorio Bellotti & Renata Piccoli. (2006) Recombinant amyloidogenic domain of ApoA-I: Analysis of its fibrillogenic potential. Biochemical and Biophysical Research Communications 351:1, pages 223-228.
Crossref
Crossref